Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984747 · ClinicalTrials.gov registry record
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 110
- Enrollment target
NCT03984747 is a clinical trial that has completed, run by Natera. The registered enrollment target is 110 participants.
The verdict
NCT03984747 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This is a multi-center prospective study designed to collect blood samples from transplant patients in order to improve Natera's method for determining allograft rejection status using the donor-derived cell-free DNA analysis, called Prospera.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2024-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03984747
The ClinicalTrials.gov registry entry for NCT03984747 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03984747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03984747 about?
NCT03984747 is a clinical study titled "Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection". This is a multi-center prospective study designed to collect blood samples from transplant patients in order to improve Natera's method for determining allograft rejection status using the donor-derived cell-free DNA analysis, called Prospera.
What is the current status of trial NCT03984747?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2018-09-14. Estimated completion is 2024-08-23.
Who is sponsoring clinical trial NCT03984747?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.